Mackenzie Financial Corp Purchases Shares of 59,582 Nu Skin Enterprises, Inc. (NUS), Report finds

Mackenzie Financial Corp Purchases Shares of 59,582 Nu Skin Enterprises, Inc. (NUS), Report finds

Mackenzie Financial Corp purchased a new position in Nu Skin Enterprises, Inc. (NYSE:NUS) during the third quarter, Holdings Channel reports. The institutional investor purchased 59,582 shares of the company’s stock, valued at approximately $3,860,000. Mackenzie Financial Corp owned approximately 0.11% of Nu Skin Enterprises at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Amalgamated Bank increased its position in Nu Skin Enterprises by 6.0% in the second quarter. Amalgamated Bank now owns 7,263 shares of the company’s stock worth $423,000 after buying an additional 414 shares in the last quarter. Legal & General Group Plc increased its position in Nu Skin Enterprises by 33.0% in the second quarter. Legal & General Group Plc now owns 29,193 shares of the company’s stock worth $1,348,000 after buying an additional 7,246 shares in the last quarter. Metropolitan Life Insurance Co. NY increased its position in Nu Skin Enterprises by 3.4% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,349 shares of the company’s stock worth $109,000 after buying an additional 77 shares in the last quarter. Cantab Capital Partners LLP increased its position in Nu Skin Enterprises by 69.5% in the second quarter. Cantab Capital Partners LLP now owns 21,821 shares of the company’s stock worth $1,008,000 after buying an additional 8,949 shares in the last quarter. Finally, Miles Capital Inc. purchased a new position in Nu Skin Enterprises during the second quarter worth about $953,000. Hedge funds and other institutional investors own 77.17% of the company’s stock.

Nu Skin Enterprises, Inc. (NYSE:NUS) traded down 0.34% during mid-day trading on Wednesday, hitting $52.39. The stock had a trading volume of 370,849 shares. The company has a 50-day moving average of $50.58 and a 200-day moving average of $55.91. Nu Skin Enterprises, Inc. has a 12-month low of $23.51 and a 12-month high of $66.04. The stock has a market cap of $2.85 billion, a price-to-earnings ratio of 21.19 and a beta of 1.66.

A number of research firms recently issued reports on NUS. Zacks Investment Research downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Thursday, October 27th. Bank of America Corporation set a $56.00 target price on Nu Skin Enterprises and gave the company a “sell” rating in a research note on Sunday, November 6th. TheStreet downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Monday, November 28th. Pivotal Research reiterated a “buy” rating and issued a $65.00 target price on shares of Nu Skin Enterprises in a research note on Sunday, December 11th. Finally, Jefferies Group LLC reiterated a “hold” rating and issued a $55.00 target price (down from $59.00) on shares of Nu Skin Enterprises in a research note on Friday, December 9th. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $57.25.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 8,000 shares of the company’s stock in a transaction that occurred on Friday, January 6th. The stock was sold at an average price of $50.00, for a total transaction of $400,000.00. Following the sale, the general counsel now owns 49,230 shares in the company, valued at $2,461,500. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 4.60% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Related posts

Leave a Comment

Mackenzie Financial Corp Purchases Shares of 59,582 Nu Skin Enterprises, Inc. (NUS)

Mackenzie Financial Corp Purchases Shares of 59,582 Nu Skin Enterprises, Inc. (NUS)

Mackenzie Financial Corp purchased a new position in Nu Skin Enterprises, Inc. (NYSE:NUS) during the third quarter, Holdings Channel reports. The institutional investor purchased 59,582 shares of the company’s stock, valued at approximately $3,860,000. Mackenzie Financial Corp owned approximately 0.11% of Nu Skin Enterprises at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Amalgamated Bank increased its position in Nu Skin Enterprises by 6.0% in the second quarter. Amalgamated Bank now owns 7,263 shares of the company’s stock worth $423,000 after buying an additional 414 shares in the last quarter. Legal & General Group Plc increased its position in Nu Skin Enterprises by 33.0% in the second quarter. Legal & General Group Plc now owns 29,193 shares of the company’s stock worth $1,348,000 after buying an additional 7,246 shares in the last quarter. Metropolitan Life Insurance Co. NY increased its position in Nu Skin Enterprises by 3.4% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,349 shares of the company’s stock worth $109,000 after buying an additional 77 shares in the last quarter. Cantab Capital Partners LLP increased its position in Nu Skin Enterprises by 69.5% in the second quarter. Cantab Capital Partners LLP now owns 21,821 shares of the company’s stock worth $1,008,000 after buying an additional 8,949 shares in the last quarter. Finally, Miles Capital Inc. purchased a new position in Nu Skin Enterprises during the second quarter worth about $953,000. Hedge funds and other institutional investors own 77.17% of the company’s stock.

Nu Skin Enterprises, Inc. (NYSE:NUS) traded down 0.34% during mid-day trading on Wednesday, hitting $52.39. The stock had a trading volume of 370,849 shares. The company has a 50-day moving average of $50.58 and a 200-day moving average of $55.91. Nu Skin Enterprises, Inc. has a 12-month low of $23.51 and a 12-month high of $66.04. The stock has a market cap of $2.85 billion, a price-to-earnings ratio of 21.19 and a beta of 1.66.

A number of research firms recently issued reports on NUS. Zacks Investment Research downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Thursday, October 27th. Bank of America Corporation set a $56.00 target price on Nu Skin Enterprises and gave the company a “sell” rating in a research note on Sunday, November 6th. TheStreet downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Monday, November 28th. Pivotal Research reiterated a “buy” rating and issued a $65.00 target price on shares of Nu Skin Enterprises in a research note on Sunday, December 11th. Finally, Jefferies Group LLC reiterated a “hold” rating and issued a $55.00 target price (down from $59.00) on shares of Nu Skin Enterprises in a research note on Friday, December 9th. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $57.25.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 8,000 shares of the company’s stock in a transaction that occurred on Friday, January 6th. The stock was sold at an average price of $50.00, for a total transaction of $400,000.00. Following the sale, the general counsel now owns 49,230 shares in the company, valued at $2,461,500. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 4.60% of the company’s stock.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Related posts

Leave a Comment